StonvexLoading…
StonvexStonvexStonvexCore line items from KN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $593.20M | $553.50M | $456.80M | $478.80M |
Operating Income | $70.30M | $51.80M | $43.40M | $90.80M |
Net Income | $44.20M | $-237.80M | $72.40M | $-430.10M |
EPS (Diluted) | $0.50 | $-2.64 | $0.79 | $-4.63 |
Total Assets | $1.05B | $1.12B | $1.46B | $1.18B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $54.20M | $130.10M | $87.30M | $48.20M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 84.89M | 87.36M | 89.09M | 91.08M |